[Advances in research on metabolic associated fatty liver disease in 2025]. [PDF]
Rao HY, Zhao JM, Yu CH, Mi YQ, Wei L.
europepmc +1 more source
[Monitoring and interventions of growth disorders and endocrine function in children with transfusion-dependent thalassemia]. [PDF]
Fan X, Huang YY.
europepmc +1 more source
[Comprehensive considerations for the diagnosis, treatment, and management of osteogenesis imperfecta]. [PDF]
Lyu XH, Dong J.
europepmc +1 more source
[Role of Intestinal Mucosal Barrier in Type 2 Diabetes Mellitus and Research Progress in Chinese Medicine Interventions]. [PDF]
Yan C, Wang Q, Zhan L.
europepmc +1 more source
[Recent Advances in the Interorgan Regulatory Roles of Adipose Tissue]. [PDF]
Li Z, Xu C, Xu R, Zhou C, Fan Y.
europepmc +1 more source
[Research progress of sarcopenic obesity and chronic liver disease]. [PDF]
Tang LY, Zhou LZ, Zhang P.
europepmc +1 more source
[The logic of survival in patients with acute liver failure]. [PDF]
Weng HL.
europepmc +1 more source
[Research progress on clinical characteristics and pathological mechanisms of lean metabolic-associated fatty liver disease]. [PDF]
He N +5 more
europepmc +1 more source
[Research progresses in ex vivo liver perfusion technology]. [PDF]
Liu QY, Zhao Q, He XS.
europepmc +1 more source
[Periodontitis and Metabolic Dysfunction-Associated Fatty Liver Disease: From Oral Dysbiosis to Hepatic Metabolic Dysregulation]. [PDF]
Wang M +5 more
europepmc +1 more source

